Sage Therapeutics, Inc. SAGE
Set alert
8.68 0.00 0.00%
At close · Jul 31
8.68 Day range 8.68
52-week range unavailable
- YTD
- +59.85%
- 1 year
- -19.63%
- Open
- 8.68
- Prev close
- 8.68
- Mkt cap
- 544.94M
- Vol
- 17.39M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.68
- High
- 8.68
- Forward P/E
- -1.30
- Beta
- 0.92
- Short ratio
- 7.21
- Inst. own
- 86.48%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 12, 2025
- 50-d avg
- 6.09
- 200-d avg
- 10.24
- 1y target
- 9.00
Analyst view
Consensus: hold
Hold
Price target (mean) 9.00 +3.7% upside
Now 8.68
- Target (low)
- 4.00
- Target (mean)
- 9.00
- Target (high)
- 26.00
Ratings (0m) 19 2 buy · 16 hold · 1 sell
- Strong buy2
- Buy0
- Hold16
- Sell0
- Strong sell1
Recommendation trend
- This month 19
- 1 month ago 20
- 2 months ago 20
- 3 months ago 19
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.44 | -1.78 – -0.99 | -0.5487 | -162.8% | 13.97M | -82.1% | 10 |
| Next quarter | -1.24 | -1.54 – -1.07 | -1.80 | +31.1% | 16.17M | +104.6% | 5 |
| Current year | -6.46 | -6.81 – -5.97 | -8.49 | +23.9% | 42.10M | -51.3% | 10 |
| Next year | -3.70 | -5.09 – -0.81 | -6.46 | +42.8% | 96.15M | +128.4% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 16, 2024 | Stifel | Maintained | Hold | Hold |
| Nov 21, 2024 | TD Cowen | Maintained | Hold | Hold |
| Nov 21, 2024 | RBC Capital | Upgrade | Underperform | Sector Perform |
| Nov 20, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Nov 20, 2024 | Needham | Reiterated | — | Hold |
| Oct 30, 2024 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Oct 30, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Oct 30, 2024 | Oppenheimer | Maintained | Perform | Perform |
| Oct 30, 2024 | Truist Securities | Maintained | Hold | Hold |
| Oct 30, 2024 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| Oct 30, 2024 | Needham | Reiterated | — | Hold |
| Oct 17, 2024 | Needham | Reiterated | — | Hold |
| Oct 9, 2024 | B of A Securities | Maintained | Underperform | Underperform |
| Oct 9, 2024 | Wedbush | Maintained | Neutral | Neutral |
| Oct 9, 2024 | Baird | Maintained | Neutral | Neutral |
| Oct 9, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Oct 8, 2024 | Needham | Reiterated | — | Hold |
| Oct 4, 2024 | RBC Capital | Downgrade | Sector Perform | Underperform |
| Aug 14, 2024 | Truist Securities | Maintained | Hold | Hold |
| Aug 6, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 2, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Aug 1, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 1, 2024 | Needham | Reiterated | — | Hold |
| Jul 30, 2024 | TD Cowen | Downgrade | Buy | Hold |
| Jul 26, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jul 25, 2024 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Jul 25, 2024 | JP Morgan | Downgrade | Overweight | Neutral |
| Jul 25, 2024 | Baird | Maintained | Neutral | Neutral |
| Jul 25, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Jul 24, 2024 | Needham | Reiterated | — | Hold |